Jun 11, 2015 Cellectar Biosciences Announces CLR1502 Development Program to be Classified as Combination Product by U.S. Food and Drug Administration Learn More
May 26, 2015 Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of Stockholders Learn More
May 21, 2015 Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs Learn More
May 20, 2015 Cellectar Biosciences to Host Conference Call on May 21st to Discuss First Quarter 2015 Results and Provide Update on Development Programs Learn More